Suppr超能文献

[社区疫情期间百日咳疫苗接种效果的流行病学评估。RENACOQ网络的儿科医生和细菌学家]

[Epidemiological estimation of the effectiveness of the pertussis vaccination during outbreaks in a community. Les pédiatres et bactériologistes du réseau RENACOQ].

作者信息

Baron S, Grimprel E, Daurat G, Cuisinet C, Ponge A, Haeghebaert S, Guiso N, Desenclos J C, Drucker J

机构信息

Réseau national de Santé publique, hôpital Saint-Maurice, France.

出版信息

Arch Pediatr. 1997 Aug;4(8):744-50. doi: 10.1016/s0929-693x(97)83413-6.

Abstract

BACKGROUND

With the recent pertussis vaccine trials, the efficacy of acellular vaccines is now well known, estimated at 85% for multicomponent vaccines. On the other hand, the estimates of whole cell vaccines efficacy varies from 36% to 98% with the different vaccines used. We evaluated the field effectiveness of the French whole cell pertussis vaccine during outbreaks in schools and centers for disabled children.

METHODS

Four limited outbreaks between 1993 and 1995 were investigated using a retrospective cohort study design. Vaccine effectiveness (VE) was assessed for the following case definition: clinical pertussis, laboratory-confirmed pertussis, epidemiologically confirmed pertussis (documented contact with a laboratory confirmed case). Immunization history was obtained by reviewing the child health record book. Effectiveness of a whole vaccination (four injections) and of a partial vaccination (one to three injections) were estimated as 1-(attack rate among vaccinated/attack rate among non-vaccinated).

RESULTS

A whole immunization conferred good protection against pertussis with an estimated VE higher than 92% in three surveys, lower in the fourth survey (84%) in which antibiotic prophylaxis was set up very rapidly. A partial immunization conferred a mild protection (median: 60%).

CONCLUSIONS

These results are consistent with a previous report about the effectiveness of this whole cell vaccine using the screening method in a hospital network survey in France. In the same way, a large efficacy trial in Senegal comparing it with an acellular bivalent vaccine estimated its efficacy at 96%. This high efficacy together with a satisfactory vaccine coverage leads to the current epidemiological profile of pertussis in childhood in France: majority of cases occurring before 6 months of age, limited outbreaks in school children, many of whom being unvaccinated or partially vaccinated.

摘要

背景

随着近期百日咳疫苗试验的开展,无细胞疫苗的疗效现已为人熟知,多组分疫苗的疗效估计为85%。另一方面,使用不同的全细胞疫苗,其疗效估计值在36%至98%之间有所不同。我们评估了法国全细胞百日咳疫苗在学校和残疾儿童中心暴发期间的现场有效性。

方法

采用回顾性队列研究设计,对1993年至1995年间的四次有限暴发进行了调查。针对以下病例定义评估疫苗有效性(VE):临床百日咳、实验室确诊的百日咳、经流行病学确认的百日咳(记录与实验室确诊病例的接触情况)。通过查阅儿童健康记录手册获取免疫史。全程接种(四针)和部分接种(一针至三针)的有效性估计为1 -(接种组的发病率/未接种组的发病率)。

结果

全程免疫对百日咳提供了良好的保护,在三项调查中估计的VE高于92%,在第四项调查中较低(84%),该项调查中抗生素预防措施很快就实施了。部分免疫提供了轻度保护(中位数:60%)。

结论

这些结果与之前一份关于该全细胞疫苗在法国医院网络调查中使用筛查方法的有效性报告一致。同样,在塞内加尔进行的一项将其与一种无细胞二价疫苗进行比较的大型疗效试验估计其疗效为96%。这种高疗效以及令人满意的疫苗接种覆盖率导致了法国目前儿童百日咳的流行病学特征:大多数病例发生在6个月龄之前,学龄儿童中暴发有限,其中许多儿童未接种疫苗或部分接种疫苗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验